Stanford V

Stanford V is a chemotherapy regimen designed for Hodgkin’s lymphoma that consists of the following:

• Mechlorethamine
• Doxorubicin
• Vinblastine
• Vincristine
• Bleomycin
• Etoposide
• Prednisone

It is a newer method than MOPP or ABVD, the two previous most common treatments for Hodgkin’s lymphoma.

The chemotherapy part of Stanford V treatment can last anywhere from 8 to 12 weeks, depending on the staging of the disease. In many cases, this is followed by radiation therapy for anywhere from 2 to 6 weeks to the affected areas of the body.

It is believed that Stanford V is at least as effective as other methods of treatment. Stanford V is a more rigorously administered form of chemotherapy, with treatments roughly twice as fast as those of other Hodgkin’s lymphoma treatments; however, this is tempered by the need for radiation therapy in most cases which is not typically required under ABVD.

• Lymphoma Information Network
• PMID 11821442
• Includes table for schedule

Template:Chemotherapeutic Agents Template:WH Template:WS